Zobair Younossi, MD, MPH

Khavir A. Sharieff, DO
Inova Transplant Center at Inova Fairfax Hospital, Falls Church, VA

David Duncan, MD
Department of Medicine at Inova Fairfax Hospital, Falls Church, VA

Zobair Younossi, MD, MPH
Center for Liver Diseases, Inova Transplant Center and Department of Medicine at Inova Fairfax Hospital, Falls Church, VA

Address: Zobair M. Younossi, MD, MPH, Center for Liver Diseases, Inova Fairfax Hospital, 3300 Gallows Rd., Falls Church, VA 22042; e-mail: zobiar.younossi@inova.com

Dr. Younossi has indicated that he has received grant or research support from the Roche and Schering-Plough corporations and is on the speakers’ bureaus of the Axcan Pharma, Roche, and Schering-Plough corporations.

This paper discusses therapies that are not approved by the US Food and Drug Administration (FDA) for the use under discussion.

Khavir A. Sharieff, DO
Inova Transplant Center at Inova Fairfax Hospital, Falls Church, VA

David Duncan, MD
Department of Medicine at Inova Fairfax Hospital, Falls Church, VA

Zobair Younossi, MD, MPH
Center for Liver Diseases, Inova Transplant Center and Department of Medicine at Inova Fairfax Hospital, Falls Church, VA

Address: Zobair M. Younossi, MD, MPH, Center for Liver Diseases, Inova Fairfax Hospital, 3300 Gallows Rd., Falls Church, VA 22042; e-mail: zobiar.younossi@inova.com

Dr. Younossi has indicated that he has received grant or research support from the Roche and Schering-Plough corporations and is on the speakers’ bureaus of the Axcan Pharma, Roche, and Schering-Plough corporations.

This paper discusses therapies that are not approved by the US Food and Drug Administration (FDA) for the use under discussion.

Khavir A. Sharieff, DO
Inova Transplant Center at Inova Fairfax Hospital, Falls Church, VA

David Duncan, MD
Department of Medicine at Inova Fairfax Hospital, Falls Church, VA

Zobair Younossi, MD, MPH
Center for Liver Diseases, Inova Transplant Center and Department of Medicine at Inova Fairfax Hospital, Falls Church, VA

Address: Zobair M. Younossi, MD, MPH, Center for Liver Diseases, Inova Fairfax Hospital, 3300 Gallows Rd., Falls Church, VA 22042; e-mail: zobiar.younossi@inova.com

Dr. Younossi has indicated that he has received grant or research support from the Roche and Schering-Plough corporations and is on the speakers’ bureaus of the Axcan Pharma, Roche, and Schering-Plough corporations.

This paper discusses therapies that are not approved by the US Food and Drug Administration (FDA) for the use under discussion.

John G. McHutchison, MD
Director, Liver Transplantation Program; Division of Gastroenterology/Hepatology, Scripps Clinic and Research Foundation; La Jolla, Calif

Zobair Younossi, MD, MPH
Section of Hepatology, Department of Gastroenterology, Cleveland Clinic

Address: Zobair Younossi, MD, Department of Gastroenterology, S40, Cleveland Clinic, 9500
Euclid Avenue, Cleveland, OH 44195

Dr. McHutchison receives grant or research support from the Schering-Plough, Amgen, Roche, and Gilead companies, has served as a consultant for Schering-Plough and Roche, and has served on speakers' bureaus for Schering-Plough, Roche, and Amgen.

Dr. Younossi receives research support from Schering-Plough, Roche, and Interferon Sciences.

John G. McHutchison, MD
Director, Liver Transplantation Program; Division of Gastroenterology/Hepatology, Scripps Clinic and Research Foundation; La Jolla, Calif

Zobair Younossi, MD, MPH
Section of Hepatology, Department of Gastroenterology, Cleveland Clinic

Address: Zobair Younossi, MD, Department of Gastroenterology, S40, Cleveland Clinic, 9500
Euclid Avenue, Cleveland, OH 44195

Dr. McHutchison receives grant or research support from the Schering-Plough, Amgen, Roche, and Gilead companies, has served as a consultant for Schering-Plough and Roche, and has served on speakers' bureaus for Schering-Plough, Roche, and Amgen.

Dr. Younossi receives research support from Schering-Plough, Roche, and Interferon Sciences.

John G. McHutchison, MD
Director, Liver Transplantation Program; Division of Gastroenterology/Hepatology, Scripps Clinic and Research Foundation; La Jolla, Calif

Zobair Younossi, MD, MPH
Section of Hepatology, Department of Gastroenterology, Cleveland Clinic

Address: Zobair Younossi, MD, Department of Gastroenterology, S40, Cleveland Clinic, 9500
Euclid Avenue, Cleveland, OH 44195

Dr. McHutchison receives grant or research support from the Schering-Plough, Amgen, Roche, and Gilead companies, has served as a consultant for Schering-Plough and Roche, and has served on speakers' bureaus for Schering-Plough, Roche, and Amgen.

Dr. Younossi receives research support from Schering-Plough, Roche, and Interferon Sciences.